Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. - Wikidata - awgldk - TriplyDB

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.

http://www.wikidata.org/entity/Q33651118

about

18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkers Alliance for aging research AD biomarkers work group: structural MRI.Early detection of Alzheimer's disease using MRI hippocampal texture The Alzheimer's disease neuroimaging initiative: progress report and future plans Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis.Independent component analysis-based classification of Alzheimer's disease MRI data.MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study.Transcriptomics of cortical gray matter thickness decline during normal aging Latent information in fluency lists predicts functional decline in persons at risk for Alzheimer disease Bi-level multi-source learning for heterogeneous block-wise missing data.Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.Estrogen: a master regulator of bioenergetic systems in the brain and body Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease.Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series.Diagnosis and biomarkers of predementia in Alzheimer's disease.Latent feature representation with stacked auto-encoder for AD/MCI diagnosis [Diagnosis without therapy: early diagnosis of Alzheimer's disease in the stage of mild cognitive impairment].New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors Boosting power for clinical trials using classifiers based on multiple biomarkers.Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.Comparing predictors of conversion and decline in mild cognitive impairment.Structural and functional neuroimaging methods in the diagnosis of dementias: a retrospective chart and brain imaging review.Subclass-based multi-task learning for Alzheimer's disease diagnosis Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Imaging approaches for dementia.Aberrant hippocampal subregion networks associated with the classifications of aMCI subjects: a longitudinal resting-state study.cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.

P2860

Q24186399-51CCD35A-517B-4655-9B94-B25A27BCA4AD Q26864063-7858DB93-EA76-4945-95EC-0931A2B945AF Q27006831-ED65C6DE-570E-4DAA-A2DF-54D9A48D4D5E Q27008249-2887F610-3927-475D-9B07-93C34CAD6994 Q27692607-7355BFB1-1364-41D6-8CC1-8D0B7F06BF1D Q27907796-7D9EB582-4EB8-456E-90C8-10A8E5D487E2 Q28749585-929B7379-3B5A-4D61-A632-8A63278B6A38 Q30399994-996EB12E-277F-4800-9EBA-F3297A1A37B1 Q30484823-7C630E8F-27C6-461E-960F-AD60D428409A Q30540746-744984F7-B328-4150-916A-CC3051DE4F13 Q30543926-054FDEAB-A7F1-4D3B-9999-383F7E2984C3 Q30579316-1B6D8766-C6EE-4CA6-A0EE-145E1DE9B850 Q30663979-66612500-8FA3-4207-9BA0-DEBEF402C88A Q30680866-0B53BAB0-4A75-4B06-8571-151097C4CB7B Q30724134-91705147-67CA-4BB6-AD94-C17C81219429 Q30971403-AC6F0A51-88D8-4F47-9326-06B8FE5F03B1 Q30981669-C539851E-9F04-4DC0-91C8-B1A7858FBE2F Q30996799-EFDB8A6B-D4B2-4BB1-8C1C-ABBDA76BA555 Q33556068-3E5B2D29-94B6-49B6-A069-AC8F57B585E1 Q33572446-6C712B6F-2A62-4CDD-BFB0-B623D18BB5A1 Q33604453-3CC63003-52DC-4000-9F90-FAA9F16303A3 Q33623924-616F7B34-A732-40CE-8A39-B3141CD73C3E Q33663207-552A0EFB-4311-4C2E-9433-BE5BE631520C Q33758587-212F57DD-AF4D-4471-92F1-E14154B4E697 Q33777509-2B82172E-8138-46EB-A1A2-785A8EC4E7ED Q33787457-F748A4D3-802A-4C81-859E-CA97E234EE49 Q33789963-2DDE0356-8AF4-4E28-8DA7-4E394ECE4A41 Q33881726-D3F1C43C-CA7C-4B3A-A7E3-A59E2B885EC3 Q33981434-B82871D2-D17B-4C5C-B3A3-6C299F40F80F Q33990250-E73A6100-F558-4AF2-9200-8D67EBDD114F Q33997421-977885CA-86A6-4F4F-A3AB-A6AB7A3FC4A7 Q33998690-1DAAAD5E-8A76-4D60-924A-259E5C3EECFF Q34003436-6BEB830E-748B-407A-84AC-EE106A53CDB7 Q34006368-CCB18469-3D46-488A-B9B6-7182248181E5 Q34014381-266822E8-265B-447E-8649-97ED74470DEC Q34055598-B655EF97-F745-41AD-BDFA-69B06A92FEDB Q34065449-8CFBD357-48D8-4305-B304-DDC5F03EE405 Q34089121-9F71DEB5-5A7C-4ED5-923C-99B619183008 Q34117433-1EB64649-9A86-469A-8F7B-6C62C1FA4ECB Q34155662-48443E7C-1157-4F67-86DF-AB107F24BE69

P2860

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.

http://www.wikidata.org/entity/Q33651118

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Combining MR imaging, positron ...... rognosis of Alzheimer disease.

@ast

Combining MR imaging, positron ...... rognosis of Alzheimer disease.

@en

type

label

Combining MR imaging, positron ...... rognosis of Alzheimer disease.

@ast

Combining MR imaging, positron ...... rognosis of Alzheimer disease.

@en

prefLabel

Combining MR imaging, positron ...... rognosis of Alzheimer disease.

@ast

Combining MR imaging, positron ...... rognosis of Alzheimer disease.

@en

P1433

Q33651118-647F646D-13A3-421B-B053-6F335FC52043

P1476

Q33651118-9DC8DDEF-56AD-4B35-84F8-1560C2338528

P2093

Q33651118-1DF98817-D480-4160-AAEF-82FA9A12CB96

Q33651118-7C8B059C-3CFD-49E2-8297-A184FD6C479C

Q33651118-8F745DC4-6BB5-45F6-B514-6E9D451D5480

Q33651118-C8C3FA3A-B3F7-41E9-BD21-182CDF48F645

Q33651118-E1357AE1-5327-46AB-978B-76E2F5FCCD20

P2860

Q33651118-06A38214-96E4-4503-9C9D-A83227EA4B0A

Q33651118-08A28791-E9E0-4C6A-8F86-2BCDB3979D58

Q33651118-103749A8-7D46-45C9-B2A3-ED064807D82C

Q33651118-1476F3A1-DD76-43EA-8014-2A9ABE9AD883

Q33651118-18E78D1C-D46B-4788-9BC3-A3339797BCC1

Q33651118-2143F269-9093-46DD-9F11-EF50260A0778

Q33651118-22F388EC-4EC5-46DF-8589-6EAAEC58A9D2

Q33651118-2A45CC2F-A3BD-4256-9903-5366C62468FB

Q33651118-2FA0EFDA-9B6D-41E9-B305-6574527B8695

Q33651118-31AB7AB5-28FB-48D4-A6E9-D55EC147AAAF

P304

Q33651118-10892B1F-4709-4880-B295-56FD10C02995

P31

Q33651118-B3C2B582-5049-46DD-A149-7C8A7CF4FE6D

P356

Q33651118-0B168CFD-6EA0-42F6-85B6-C47DCD3E810C

P433

Q33651118-C055D5C6-7909-48E5-9BA5-6C3CFFE1963E

P478

Q33651118-6B84098B-329A-4B68-8824-961760B79F12

P50

Q33651118-741424F3-CFE4-4C2B-9D63-7DC275E55E90

Q33651118-C49C3739-9AD4-4496-A41B-8CB6E9C8CCD9

Q33651118-CDA797E2-2840-47EA-83E0-932251398ECA

Q33651118-D6F57524-8065-4B47-9446-C4D2130918AE

Q33651118-E2B7314C-99DB-4C0E-B86C-A7C6071AC4D5

P577

Q33651118-D21B3A75-D9F4-43AC-972A-0067E3E849B8

P698

Q33651118-B509DA72-1168-4D69-80AC-A61F8CB88B5E

P921

Q33651118-8ABBF084-6769-45B9-BFAD-7579075BFA96

Q33651118-CF51C20C-44CB-4698-98AD-80CEBB0F2220

P932

Q33651118-D2C7878F-9F57-49D6-AD80-A32C7E972582

P356

P1433

American Journal of Neuroradiology

P1476

Combining MR imaging, positron ...... rognosis of Alzheimer disease.

@en

P2093

D J Hagler

http://www.w3.org/2001/XMLSchema#string

D Karow

http://www.w3.org/2001/XMLSchema#string

J Brewer

http://www.w3.org/2001/XMLSchema#string

L K McEvoy

http://www.w3.org/2001/XMLSchema#string

R G Jennings

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers of Alzheimer's disease

“Mini-mental state”

Cortical Surface-Based Analysis

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

Automatically parcellating the human cerebral cortex

Measuring the thickness of the human cerebral cortex from magnetic resonance images

High-resolution intersubject averaging and a coordinate system for the cortical surface

The Clinical Dementia Rating (CDR): current version and scoring rules

P304

347-354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3174/AJNR.A1809

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Kristine Beate Walhovd

Christine Fennema-Notestine

Alzheimer's Disease Neuroimaging Initiative

P577

2010-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20075088

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2821467

http://www.w3.org/2001/XMLSchema#string